Authors:Béla Hunyady, Zsuzsanna Gerlei, Judit Gervain, Gábor Horváth, Gabriella Lengyel, Alajos Pár, László Rókusz, Ferenc Szalay, László †Telegdy, István Tornai, Klára Werling, and Mihály Makara
-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA, 2012, 308 (24), 2584–2593.
Makara, M., Horváth, G., Szalay, F., et al.: Organizational characteristics of treatment for chronic
Authors:William Van Gordon, Edo Shonin, and Mark D. Griffiths
enhancement, and psychopharmacology ( Dhuffar & Griffiths, 2015 ; Griffiths, 2012 ; Rosenberg et al., 2014 ). However, treatment effectiveness research for sex addiction is underdeveloped and most of the aforementioned interventions are based on
Authors:Erika Maka, László Imre, Zsolt Somogyvári, and János Németh
Early Treatment for Retinopathy of Prematurity Cooperative Group: Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized
Introduction The last decade has witnessed a resurgence of interest in serotonergic psychedelics, such as lysergic acid diethylamide (LSD) and psilocybin, for the treatment of a range of psychopathologies. Whilst individuals self-medicate with